Tianzhen He

7PUBLICATIONS
18CO-AUTHORS
Field theory and string theoryPredictive and prognostic markersMolecular targetsMedical bacteriologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jan 14, 2026
TRIP13 promotes the expansion and immunosuppression of CD4+Foxp3+ regulatory T cells by sustaining HAT1 stability.

Tianzhen He, Liwen Zhao, Chu-Ting Feng

|Jul 22, 2025
ALOXE3 expression predicts poor prognosis and modulates immune infiltration in colon adenocarcinoma.

Liwen Zhao, Liya Zhao, Siyu Ye

|Oct 14, 2024
TRIP13: A promising cancer immunotherapy target.

Shengnan Jing, Liya Zhao, Liwen Zhao

|Jun 06, 2024
LL37/FPR2 regulates neutrophil mPTP promoting the development of neutrophil extracellular traps in diabetic retinopathy.

Xueying Lou, Hongliang Chen, Songwei Chen

|Jun 01, 2022
Collective analysis of the expression and prognosis for LEM-domain proteins in prostate cancer.

Tianzhen He, Yulian Zhang, Xueyu Li

|Dec 23, 2021
Integrative computational approach identifies immune-relevant biomarkers in ulcerative colitis.

Tianzhen He, Kai Wang, Peng Zhao

Pageof 2

Frequent Collaborators

3 joint publications

Yong-Jing Gao

2 joint publications

Xin Chen

1 joint publications

De Yang

1 joint publications

Xiao-Qing Li